drugset / Trial / NCT00156156
Study of Asoprisnil in the Treatment of Uterine Fibroids.
Non-randomizedParallel-groupSingle-blindTreatment
Summary
The objective of this study is to determine the long-term safety of asoprisnil in women with abnormal uterine bleeding associated with uterine fibroids.
Timeline
- Start
- 2004-11
- Primary completion
- 2007-02
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Asoprisnil | Other / unclassified | 10 mg | Oral |
| Subject | Asoprisnil | Other / unclassified | 25 mg | Oral |